Company
ChinaWuhan Biocause Pharmaceutical Development Co., Ltd., Wuhan, China – FDA Inspections
Inspection records and compliance data for Wuhan Biocause Pharmaceutical Development Co., Ltd. in Wuhan. 5 FDA inspections on record, 2 Form 483s, last inspected March 14, 2025.
Company Profile
This profile covers Wuhan Biocause Pharmaceutical Development Co., Ltd. based in Wuhan, China.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 4
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected July 23, 2010. Last inspected March 14, 2025.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 14, 2025 | Not classified | Human Drugs | 1267912 |
| August 24, 2018 | VAI | Human Drugs · Drug Quality Assurance | 1069379 |
| July 22, 2016 | VAI | Human Drugs · Drug Quality Assurance | 982641 |
| February 28, 2014 | VAI | Human Drugs · Drug Quality Assurance | 873586 |
| July 23, 2010 | VAI | Human Drugs · Drug Quality Assurance | 680329 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
Jiangxi Synergy Pharmaceutical, Co., Ltd.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Harman Finochem Limited
Natco Pharma Ltd. - Chemical Division
Somerville Acquisitions, Inc.
Cadila Pharmaceuticals Limited
Zach System S.A.
Aarti Pharmalabs Limited
Arch Pharmalabs Ltd.
Company Information
Name
Wuhan Biocause Pharmaceutical Development Co., Ltd.
FEI Number
3004202226
Address
Bldg. 1, 4th Floor, Zhuankou Economic Development, Hi-Tech Industrial Park, Wuhan, China
Country
China
ID: 79c352a3-22a2-471e-abbe-1802683656eb